Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Knowing what to invest in at age 40 is crucial for building wealth. Explore key insights to guide your investment choices.
6,926 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Alphabet’s cloud and AI services are drawing more enterprise buyers. The June market backdrop intensifies the case fo...
A Ukrainian national pleaded guilty in a high-profile Conti ransomware case, highlighting the financial risks of cybe...
In many American cities, affordable homes and Section 8 properties are hard to find. This in-depth guide explains why...
SpaceX’s IPO spectacle invites big questions. History shows that the right move isn’t chasing the initial hype, but b...
Scott Bessent used a CNBC interview to frame Mamdani as a central Democratic figure and to outline a bold plan to bro...
Greece rolls out a four-satellite network that detects fires as small as four meters wide, aiming to cut wildfire los...
Europe endures a blistering heatwave as the U.S. relies on widespread air conditioning. A climate tech executive outl...
In the first half of 2026, Sandisk towered over the S&P 500. This article explains the drivers behind that outperform...
Even careful savers slip into traps that quietly erode returns. This guide lays out six big money mistakes to avoid a...
A July briefing shows AI use is widespread in real estate, but 55-point gaps between usage and perceived value persis...
As AI reshapes tech investing, two groups rise: hyperscaler stocks and AI infrastructure stocks. Learn how they inter...